70
E. Hamnevik et al. / Journal of Molecular Catalysis B: Enzymatic 99 (2014) 68–78
harvested by centrifugation at 3800 × g for 13 min at 4 ◦C. Bacteria
were resuspended in 20 ml Binding Buffer (20 mM sodium phos-
phate, 20 mM imidazole, 500 mM NaCl, 0.02% sodium azide, pH
7.5) fortified with protease inhibitors (EDTA-free Complete, Roche)
and 20 g/ml DNaseI. Cells were lysed using a Cell disruptor Z
plus series (Constant Systems LTD) and debris was removed by
centrifugation at 27,200 × g for 1 h at 4 ◦C. The supernatant was
transferred to a conical 50 ml tube and 2.5 ml Ni2+-immobilized
metal ion affinity chromatography (IMAC) gel solution (Chelating
SepharoseTM fast flow, GE Healthcare) equilibrated with Bind-
ing Buffer (75% v/v gel) was added to the lysate and the slurry
was incubated at 4 ◦C for 1 h. The gel/lysate slurry was subse-
quently centrifuged at 100 × g at 4 ◦C and the supernatant was
discarded. Washing Buffer (Binding Buffer containing 100 mM imi-
dazole) was added to a total volume of 20 ml and gel slurry was
incubated at 4 ◦C for 10 min before centrifuged as above. The wash-
ing step was repeated two additional times. Elution of ADH-A was
achieved by adding 5 ml of Elution buffer (Binding Buffer con-
taining 300 mM imidazole) to the IMAC gel. The gel slurry was
transferred to a conical 15 ml tube and incubated for 20 min at
4 ◦C. The gel–buffer mix was centrifuged at 140 × g at 4 ◦C and
the supernatant was transferred to a new 15 ml conical tube.
This elution step was performed twice. The eluted fractions were
pooled and concentrated down to 2.5 ml using a spin-column
(Vivaspin 20, 10,000 MW cut-off, Sartorius Stedim Biotech). The
concentrated sample was desalted using a PD-10 column (GE
Healthcare) equilibrated with Desalting Buffer (0.1 M sodium phos-
phate, 10 M ZnSO4, 0.02% sodium azide, pH 7.4) according to
the manufacturer’s protocol. The purified enzyme sample was
stored at 4 ◦C. Enzyme purity was controlled by SDS–PAGE and
staining with Coomassie Brilliant Blue R-250. The molar extinc-
tion coefficient at 280 nm was determined to be 31,500 cm−1 M−1
by measuring the absorbance in a UV-1700 Pharmaspec UV–vis
spectrophotometer (Shimadzu) with a concomitant determination
of the ADH-A concentration by quantitative amino acid analy-
sis.
2.6. Zinc-dependent functional integrity
Purified ADH-A was stored at 4 ◦C in either Desalting Buffer or
Desalting Buffer devoid of ZnSO4 during 40 and 60 days, respec-
tively. Aliquots were removed at different time intervals and
remaining enzyme activity was determined. Initial reaction veloci-
ties were measured in 0.1 M sodium phosphate, pH 7.0 at 30 ◦C and
1% (v/v) acetonitrile with final concentrations of 5 mM acetophe-
none and 0.4 mM NADH.
2.7. pH-dependence of enzyme activity
The pH dependencies of kcat and kcat/Km for wt ADH-A and
ADH-A H39N-catalyzed oxidation of S-5 and reduction of 6 were
determined in the pH range of 5–9. Reactions were performed in
96-well polystyrene plates (Nunc) in 0.1 M sodium phosphate (pH
5–8.5) or 0.1 M glycine (pH 8.5–9.0) at 30 ◦C and 1% (v/v) acetoni-
trile with final concentrations of 0.2–7.5 mM S-5 and 1.6 mM NAD+
in the oxidation reactions and, 0.18–7.0 mM 6 and 0.4 mM NADH
in the reduction reactions. Reduction or oxidation of the coenzyme
NADH of 3440 M−1 cm−1. Kinetic parameters were determined as
described above. Apparent acid constants were extracted by fitting
expressions for titration of one- or two-proton systems (Equations
(1) and (2), respectively), where LH is the titrated parameter kcat or
kcat/Km. The extra parameters for a two-proton system were only
included if justified by an F-test. Curve fitting was performed with
program RFFIT in SIMFIT.
LHA[H+] + LA−Ka1
LH
=
=
(1)
Ka1 + [H+]
LH2A[H+]2 + LHA−[H+]Ka1 + Ka1Ka2LA2−
LH
(2)
K
a1Ka2 + [H+]Ka1 + [H+]2
2.8. Product inhibition
2.5. Steady state kinetics
The steady state kinetics was analyzed in the presence of
increasing concentrations of either product (6 and NADH) in the
oxidative direction i.e. S-5 oxidation and NAD+ reduction. Mea-
surements were performed as described above in the paragraph
describing the steady state kinetics measurements. Final con-
centrations of alcohol were 0.12–7.5 mM, and 1.6 mM NAD+ and
0–0.2 mM NADH or 0–3 mM 6. Final concentrations for coen-
zyme reduction were 0.015–3.6 mM NAD+ with 7.5 mM S-5 and
0–0.12 mM NADH or 0–5 mM 6. The Michaelis–Menten equation
was fitted to the velocity data using MMFIT and the fits were graph-
ically presented as double-reciprocal plots.
Steady state kinetic parameters for ADH-A, or the H39N mutant,
were obtained by measuring initial velocities in the presence of
varying concentrations of 1-propanol (1, Fig. 1), 2-propanol (2),
acetone (3), benzyl alcohol (4), (S)-1-phenylethanol (S-5), (R)-
1-phenylethanol (R-5), acetophenone (6), 2-phenylethanol (7),
(S)-1-phenyl-1,2-ethanediol (S-8), (R)-1-phenyl-1,2-ethanediol (R-
9), 2-hydroxy acetophenone (9), (S)-3-phenyl-1,2-propanediol
(S-10), (R)-3-phenyl-1,2-propanediol (R-10), and in the presence
of saturating concentrations of NAD+ or NADH. All reactions were
performed in 0.1 M sodium phosphate, pH 8.0 at 30 ◦C and 1% (v/v)
acetonitrile. Final concentrations were 6–100 mM 1–3, 1.8–30 mM
4, 0.11–7.5 mM S-5, 0.3–10 mM R-5, 0.1–7 mM 6, 0.38–12.5 mM 7,
1.7–28 mM S-8, 0.1–28 mM R-8, 0.18–12.5 mM 9, 0.1–50 mM S-10
and R-10, in the presence of 1.6 mM NAD+ (18 × Km) in the oxidation
of alcohols and 0.4 mM NADH (10 × Km) when reducing ketones.
The kinetic parameters in the presence of varied concentrations of
coenzymes were determined in 0.015–1.6 mM NAD+ and 7.5 mM
S-5 (12 × Km) and 0.005–0.4 mM NADH and 5 mM 6 (4.2 × Km).
Reduction of NAD+ or oxidation of NADH was monitored at 340 nm
in a UV-1700 Pharmaspec UV–vis spectrophotometer (Shimadzu).
The kinetic parameters, kcat and Km were extracted after fitting the
Michaelis–Menten equation by non-linear regression to the ini-
tial velocity data with program MMFIT (in the SIMFIT package,
2.9. Regioselectivity
R-5 or S-5 (60 mM) were mixed with 1.6 mM NAD+, 60 mM
sodium pyruvate, 2 U/ml l-lactic dehydrogenase (Sigma) and 3 M
of ADH-A in 0.1 M ammonium bicarbonate to a total volume of
10 ml. The reactions were incubated at 30 ◦C for 10 h in the dark.
CDCl3 (2.4 ml) was added to each reaction vial, forming a two-phase
system. The phases were mixed by vortexing for 5 s and were subse-
quently allowed to separate. The CDCl3 phases were transferred to
new vials. Aliquots from the CDCl3 phases were analyzed by reverse
phase HPLC on an Ascentis C-18 column (Supelco, 25 cm × 4.6 mm,
5 m) using an isocratic elution of 37% (v/v) methanol in water and
0.1% (v/v) of formic acid.
raw data after fitting the equation v0 = ((kcat/Km)[S])/(1 + [S]/Km
)
NMR investigations of the reaction products were carried out
on a Varian Unity Inova (1H at 499.94 MHz, 13C at 125.7 MHz)
with program RFFIT.